Reducing Treatment Complexity in Older Adults with T2DM: The Role of Fixed-Ratio GLP-1 Receptor Agonist/Insulin Combinations
Released On
October 28, 2022
Expires On
October 28, 2023
Media Type
Internet
Completion Time
60 minutes
Specialty
Geriatrics, Endocrinology, Home Care, Primary Care
Topic(s)
Diabetes, T2DM
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by Med Learning Group and Ultimate Medical Academy/Complete Conference Management (CCM).
This activity is supported by an educational grant from Sanofi US.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
- Nurses — 1.0 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This educational activity is intended for geriatricians, endocrinologists, primary care clinicians (including physicians, nurse practitioners, physician assistants, nurses and consultant pharmacists), and managed care professionals caring for older adults with T2DM overall and in long-term care settings.
Program Overview
This activity will address the challenges faced by clinicians in managing older patients with T2DM. Participants will be equipped with an enhanced ability to apply current guideline recommendations and clinical data to management plans, personalize diabetes treatment for older adults in long-term care facilities and in the community, and gain greater knowledge of the rationale for using fixed ratio combinations of basal insulin and GLP-1 receptor agonists in older adults with T2DM.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Evaluate current guidelines recommendations and clinical data pertinent to the management of T2DM in older adults.
- Create personalized treatment plans for older patients with T2DM in long-term care facilities and in the community.
- Explain the clinical rationale for using fixed ratio combinations of GLP-1 receptor agonists and basal insulin in older adults in community and LTC settings.
Faculty
Jay H. Shubrook Jr, DO, FACOFP, FAAFP, BC-ADM
Professor, Primary Care Department
Director, Clinical Research and Diabetes Services
College of Osteopathic Medicine
Touro University California
Vallejo, CA
Richard E. Pratley, MD
Samuel E. Crockett Chair in Diabetes Research
Medical Director-Advent Health Diabetes Institute
Senior Investigator and Diabetes Program Lead, Advent Health
Translational Research Institute
Adjunct Professor of Medicine, Johns Hopkins University School of Medicine
Orlando, FL
Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP
Vice-Chair & Allen I. White Distinguished Professor
Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences
Washington State University
Spokane, WA
Phyllisa Deroze, PhD
Director of Research at dQ&A
Founder of Black Diabetic Info
Pompano Beach, Florida
Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education. This CME activity was planned and produced in accordance with the ACCME Essentials.
Credit Designation Statement
Med Learning Group will designate this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Nursing Credit Information
This program would be beneficial for nurses involved in the care of patients with diabetes.CNE credits: 1.0 ANCC Contact Hour.
CNE Accreditation Statement
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
Commision on Dietetic Registration
This program has received prior approval with the Commission on Dietetic Registration for dietitians and RDs. It is the responsibility of the dietitians to log the MLG activity into their CDR activity log in order to receive credit. Dietitians should also keep their certificate of completion in the event they are randomly audited by CDR. Dietitians may submit feedback on the activity to qualityCPEU@eatright.org
AAFP Credit Information
The AAFP has reviewed Reducing Treatment Complexity in Older Adults with T2DM: The Role of Fixed-Ratio GLP-1 Receptor Agonist/Insulin Combinations and deemed it acceptable for up to 1.00 Enduring Materials, Self-Study AAFP Prescribed credits. Term of Approval is from 10/28/2022 to 10/28/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosures of Conflicts of Interest
Jay H. Shubrook Jr, DO, is a consultant for Bayer and Novo Nordisk.
Richard E. Pratley, MD, discloses as of June 11, 2011 all services rendered by Richard E. Pratley, MD are paid directly to AdventHealth, a non-profit organization. Dr. Pratley does not receive any direct or indirect compensation for these services.
Joshua J. Neumiller, PharmD, is a consultant for Sanofi and Bayer. He is also a member of a speakers’ bureau for Dexcom.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
Cindy Lampner, MSLIS, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Melissa Johnson, Senior Program Manager for Med Learning Group, has nothing to disclose.
Amanda Jenkins, Program Manager for Med Learning Group, has nothing to disclose.
Natalie Smith, Program Coordinator for Med Learning Group, has nothing to disclose.
Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the enduring activity.
- Complete posttest and evaluation form online.
Participants will receive their certificate as a downloadable file.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions, please contact Med Learning Group at info@medlearninggroup.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://medlearninggroup.com/privacy-policy/"
Americans with Disabilities Act
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com
